STO Equity Snapshot

KLAR Weekly Equity Report

Klaria Pharma Holding AB (publ.)

Interactive chart JSON snapshot
Latest Close 0.80 SEK 12 Jun 2026
1W Return 1.4% latest completed week
4W Return -15.6% short-term follow-through
12W Return 1.6% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 2.5x vs 13-week average
Company Brief

What the company does

Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatriptan, a novel the treatment of migraine which is in final stage of approval; Epinephrine/Adrenaline which is in Phase I clinical trial for the treatment of acute allergic reaction; and Sirolimus which is in pre-clinical stage for prevention of organ transplant rejection. The company is also involved in commercialization and sale of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquartered in Uppsala, …

Snapshot

What the weekly tape is saying

KLAR closed the latest completed week at 0.80 SEK. The 4-week return is -15.6% and the 12-week return is 1.6%. Trend Signal is inactive, Market Dynamics is -0.55. Setup signature: Risk-first tape with a 39/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -3.5%
Volume 2.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 26 Persistence of active Trend Signal over the last year and current streak.
Momentum 16 Blend of 4-week and 12-week follow-through.
Dynamics 25 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 66 Relative leadership and short-term RS change.
Volume 100 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
0.83 SEK
Vs Trend Line
-3.5%
Fair Value
0.63 SEK
Vs Fair Value
27.8%
52W High
1.33 SEK
52W Low
0.40 SEK
Drawdown
-39.8%
Range Position
43.4%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.4%
4W -15.6%
12W 1.6%
26W 38.1%
52W 100.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
25
52W Active Breadth
48.1%
Sector Scope
SE Healthcare
Sector Rank
53 of 158
Sector Percentile
66.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.55
4W MD Change
-194.0%
Relative Strength
7.28
4W RS Change
-77.3%
Expectation
Undecided
Probability
51.41%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
11.7M
13W Average
4.7M
52W Average
3.5M
Vs 13W
2.5x
Vs 52W
3.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
12.0%
52W Volatility
12.2%
Upside Weeks
27
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
10.8% / -7.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
SEK
Market Cap
192.8M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 0.80 SEK 1.4% 0.83 SEK 0.63 SEK -0.55 7.28 11.7M Off
5 Jun 2026 0.79 SEK -0.4% 0.82 SEK 0.62 SEK -0.44 6.52 4.3M Off
29 May 2026 0.79 SEK 1.0% 0.81 SEK 0.62 SEK -0.30 6.85 5.7M On
22 May 2026 0.79 SEK -17.3% 0.80 SEK 0.62 SEK -0.33 6.21 5.8M On
15 May 2026 0.95 SEK 13.0% 0.79 SEK 0.62 SEK -0.19 32.10 6.3M On
8 May 2026 0.84 SEK -4.1% 0.77 SEK 0.61 SEK -0.18 15.14 6.1M On
1 May 2026 0.88 SEK -4.3% 0.76 SEK 0.61 SEK 0.04 19.28 2.3M On
24 Apr 2026 0.92 SEK -15.3% 0.75 SEK 0.61 SEK 0.17 21.60 4.8M On
17 Apr 2026 1.08 SEK -11.5% 0.74 SEK 0.61 SEK 0.08 37.92 3.5M On
10 Apr 2026 1.22 SEK 28.2% 0.72 SEK 0.61 SEK -0.06 57.55 5.4M On
3 Apr 2026 0.95 SEK 7.0% 0.70 SEK 0.60 SEK -0.25 27.75 2.5M On
27 Mar 2026 0.89 SEK 12.9% 0.69 SEK 0.60 SEK -0.22 21.71 1.9M On
20 Mar 2026 0.79 SEK -2.7% 0.68 SEK 0.60 SEK -0.09 6.21 1.2M On
13 Mar 2026 0.81 SEK 1.3% 0.67 SEK 0.60 SEK 0.12 1.99 2.1M On